UroGen Pharma

Discussion in 'Biotech Startups' started by anonymous, Oct 10, 2019 at 10:35 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest


    That whole side of the company is beyond messed up. However it all can be funneled back to the leader. The land of the misfit toys = MA. Will be the cause of lack of sales.
     

  2. anonymous

    anonymous Guest

    For the love of god can we just get our stock consistently above $30-$35?
     
  3. anonymous

    anonymous Guest

    no. Never. Hell no. Nada. Not gonna happen
     
  4. anonymous

    anonymous Guest

    Rhode Island no better.
     
  5. anonymous

    anonymous Guest

    Nurse Fun Size!
     
  6. anonymous

    anonymous Guest

    I am just glad he has resolved all reimbursement issues per the call today. Finally he’s pulling his weight and being a resource.

    Thank you for cleaning up the mess and being such an asset as the VP of MA. We couldn’t have done it without you.
     
  7. anonymous

    anonymous Guest

    This post is laughable for multiple reasons.
     
  8. anonymous

    anonymous Guest

    What are the remaining managed care/ reimbursement issues?
     
  9. anonymous

    anonymous Guest

    I like how you continuously try to bait to identify the poster. If you don’t know by now you shouldn’t be working here, it’s apparent the VP of MA has convinced you with his BS.

    And if you are the VP of MA, nice job on that call Pinocchio.
     
  10. anonymous

    anonymous Guest


    Looks like SB gets up early to post on CP - he is his biggest and one of two fans. The other being TS as he promoted her ass when she is not qualified.

    FYI - no one believes the BS you spew on conference calls. Go back to Dendreon.
     
  11. anonymous

    anonymous Guest


    Are there still company wide national reimbursement issues... ?

    this would not identify any individual territory.
     
  12. anonymous

    anonymous Guest


    A reimbursement issue is a reimbursement issue even if it is a N=1. And yes there are still issues.
     
  13. anonymous

    anonymous Guest

    Could not have said it better myself. It doesn’t matter what the current issues are when the old issues are being covered up. How about we focus on the mess left to clean up from the early days?

    the field has figured out a way to navigate any current reimbursement/managed cared issues now without needing to go through the VP of MA or his primary minion. The one thing that shouldn’t be tolerated are lies, something Mr SB has become an expert at.
     
  14. anonymous

    anonymous Guest

    We want SALES to rapidly grow.

    If there are NO national level reimbursement issues at this point then SALES should be increasing across the Nation.

    Is this happening?

    Great work by the field SALES team in navigating continued localized reimbursement issues and getting MORE customers to try the drug.
     
  15. anonymous

    anonymous Guest

    I don’t believe there are major current managed care issues impacting current sales. There are still some lingering older issues which could impact future sales depending on how we handle them as a company.

    But yes, it is concerning sales haven’t increased at the rate we would like considering there aren’t any huge obstacles. The product is a pain in the ass from a logistics standpoint and PEF to instillation cycle is way too complex.

    That may be the big issue here. Seems we went out of our way to make this the most complicated process ever, starting with that miserable dec letter and cardinals incompetence.
     
  16. anonymous

    anonymous Guest


    Which once again circles back to SB. Such a mental midget that has screwed the launch since day 1.. even before. Dec letter, cardinal, trial card— they all are managed by his incompetent ass.
     
  17. anonymous

    anonymous Guest

    There are some questionable leaders here. SB is at the top.
     
  18. anonymous

    anonymous Guest

    Q1 sales were less than Q4.

    Are SALES going to GROW moving forward?
     
  19. anonymous

    anonymous Guest

    sales would have the potential to grow of the shitty leadership was removed. If they stay then I see no growth on the horizon.
     
  20. anonymous

    anonymous Guest

    Such a shame that incompetent and/or jealous team members feel the need to blame others for their inability to grow business. It’s easy to tell from these posts who are the cranky and incapable FRMs, TBMs, and RBMs. If you want to point a finger then stand in the mirror. You’ll clearly see who the problem is.